Home/Filings/4/0001415889-24-010099
4//SEC Filing

Bashan Dror 4

Accession 0001415889-24-010099

CIK 0001006281other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 5:30 PM ET

Size

6.1 KB

Accession

0001415889-24-010099

Insider Transaction Report

Form 4
Period: 2023-04-01
Bashan Dror
DirectorPRESIDENT AND CEO
Transactions
  • Award

    Common Stock

    2024-04-01+263,9602,149,418 total(indirect: By Trust)
Holdings
  • Common Stock

    132,516
Footnotes (2)
  • [F1]Represents fully-vested restricted shares of common stock of Protalix BioTherapeutics, Inc., awarded to the Reporting Person under the Amended and Restated Protalix BioTherapeutics, Inc. 2006 Stock Incentive Plan, as amended (the "Plan").
  • [F2]To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Plan must be registered in the name of a trustee.

Issuer

Protalix BioTherapeutics, Inc.

CIK 0001006281

Entity typeother

Related Parties

1
  • filerCIK 0001781450

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 5:30 PM ET
Size
6.1 KB